That news came as the company replaced CEO and co-founder Chris Martin with Novartis vet Mallik. The following month, ADC brought in another …
ADC Therapeutics pulls the plug on Zynlonta study after partial FDA hold | Fierce Pharma
Share This Story, Choose Your Platform!
About the Author:
